IOM report highlights benefits of pediatric drug studies

A report released Feb. 29th by the Institute of Medicine (IOM) provided a review of the benefits of current federal laws that offer incentives for or require drug and biologic developers to conduct pediatric studies.  The report also highlighted several areas where...